RFA
IART icon

Reilly Financial Advisors’s Integra LifeSciences IART Stock Holding History

Reilly Financial Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
2
– – ﹤0.01% 1159
2021
Q3 		$0 Hold
2
– – ﹤0.01% 977
2021
Q2 		$0 Buy
+2
New +$141 ﹤0.01% 1035

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Reilly Financial Advisors's IART Position: Q4 2021 in Review

Reilly Financial Advisors held its Integra LifeSciences (IART) position steady in Q4 2021 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Reilly Financial Advisors first reported a position in IART in Q2 2021 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

  • Reilly Financial Advisors held 2 shares of Integra LifeSciences worth $0 as of Q4 2021.
  • Reilly Financial Advisors left its Integra LifeSciences share count unchanged in Q4 2021.
  • Integra LifeSciences made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #1159 holding.
  • Reilly Financial Advisors first reported a position in Integra LifeSciences in Q2 2021 and has held it in 3 quarters since.
  • 277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.